Stock ALZCHEM GROUP AG
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News AlzChem Group AG Deutsche Boerse AG

Equities

DE000A0AHT46

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
EQ
Alzchem : receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
PU
Transcript : AlzChem Group AG, Q1 2024 Earnings Call, Apr 30, 2024
Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
EQ
AlzChem : Quarterly Statement Q1 2024
PU
AlzChem : Corporate News Q1 2024
PU
Alzchem : seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
PU
AlzChem Group AG Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Young researchers in action: Chemistry Olympiad as a guest at Alzchem
PU
AlzChem : Information pursuant to Section 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018/1212
PU
Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
EQ
German arms industry receives EU millions for projects
DP
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
EQ
Transcript : AlzChem Group AG, 2023 Earnings Call, Mar 01, 2024
Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success
EQ
AlzChem Group AG Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
AlzChem Group AG Reports Earnings Results for the Full Year Ended December 31, 2023
CI
AFR: Alzchem Group AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
Alzchem Group AG: Long-Covid: New clinical studies show high efficacy of creatine supplementation
EQ
AlzChem : Happy New Year 2024
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACT Stock
  4. Stock
  5. News AlzChem Group AG
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW